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Acute respiratory viral infections are a major cause of morbidity in pediatric pa-
tients.1 Although they are most often self-limited and confined to the upper res-
piratory tract, they lead to a substantial number of upper or lower respiratory tract
complications. Therefore, accurate and rapid diagnosis of respiratory virus infection
is essential for the initiation of early treatment and the prevention of viral spread. 
Several studies evaluating polymerase chain reaction (PCR)-based methods for
the detection and typing of respiratory viruses were reported.2,3 The adenovirus
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Purpose: Early identification of causative agents in lower respiratory infection of
pediatric patients can reduce morbidity and prevent an overuse of antimicrobials.
Two kinds of multiplex polymerase chain reaction (PCR) and a commercial shell
vial viral culture were performed to identify causative agents in pediatric patients.
Materials and Methods: Nasopharyngeal aspirates of 220 children diagnosed
with viral pneumonia were obtained. Two kinds of multiplex PCR (SeeplexTM RV
detection kit, and LabopassTM RV detection kit), and a shell vial culture by R-Mix
were performed. Results: Positive samples from 220 total samples by two
multiplex PCRs were 52.7% and 46.4%, respectively. We also cultured 103 sam-
ples that showed positive results of the adenovirus, influenza virus, parainfluenza
virus, and respiratory syncytial virus (RSV) by two multiplex PCR. The RSV was
most frequently detected in 53.0% (Seeplex) and 51.7% (Labopass) of patients.
The detection rate of adenovirus (AdV) was 10.3% and 12.1%, influenza virus
(IFV) A and B was 12.5% and 3.4%, and parainfluenza virus (PIFV) 1, 2, and 3
were 2.9% and 2.6%. Shell vial cultures showed concordant results with each
multiplex PCR by 96.1% and 77.7%, respectively. Sequencing results were 90%
consistent with multiplex PCR. Conclusion: Multiplex PCR showed more posi-
tivity than the shell vial culture and it can be an effective primary test. Other com-
plementary efforts such as viral cultures and sequencing analysis could be
considered, according to clinical and laboratory conditions.  
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INTRODUCTION
(AdV), influenza virus (IFV), parainfluenza virus (PIFV),
and respiratory syncytial virus (RSV) have been identified
as significant pathogens in community-acquired and noso-
comial respiratory infections.4,5 Recently, some respiratory
viral infections caused by IFV, enterovirus (EnV), or AdV
may now benefit from specific antiviral treatment.6-8
The aim of this study is to evaluate and suggest clinical
usefulness of two kinds of multiplex PCR for identifying
causative viruses in pediatric viral pneumonia, which is the
most severe lower respiratory infection in children. 
Sample collection
Nasopharyngeal aspirates from 220 pediatric patients
during a period of 6 months were obtained by a mucus
extractor (Sewoon Inno-Vision Medical, Seoul, Korea)
and transferred to each vial of the universal transport
medium (Diagnostic Hybrids, Inc., Athens, OH, USA). All
220 pediatric patients were admitted with symptoms of
severe lower respiratory infection. For definitions of cases,
moderate to severe lower respiratory infections were deter-
mined according to the World Health Organization (WHO)
recommended surveillance standards, 2nd edition (1999).
Lower respiratory viral infections were diagnosed by an
expert pediatrician through physical examinations, chest
X-rays, blood tests, erythrocyte sedimentation rate (ESR),
and C-reactive protein (CRP), excluding bacterial origin.
The 220 aspiration samples were immediately made
aliquot and stored at -75˚C until nucleic acid extraction, viral
culture, or sequencing analysis proceeded. All patients’ sam-
ples were collected according to the protocols of the Institu-
tional Review Board of Yonsei University Health System. 
Nucleic acid extraction
QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Ger-
many) with automated QIAcube® (QIAGEN) was used to
extract nucleic acid. The 220 nucleic acid extracts were
kept in a deep freezer at - 75˚C until analysis.
Multiplex PCR for detection of respiratory virus
SeeplexTM RV detection kit 
(http://www.seegene.co.kr/en/index.php)
Nucleic acids extracted from nasopharyngeal aspirates
were used for the synthesis of first-strand cDNAs by Mol-
oney murine leukemia virus reverse transcriptase (Prome-
ga, Madison, WI, USA). The SeeplexTM RV detection kit
(Cosmo Genetech, Seoul, Korea) contained A and B sets of
primers designed by highly conserved regions of genetic
sequences for the 12 respiratory viruses. The SeeplexTM kit
is designed to identify AdV, human metapneumovirus
(hMPV), Human coronavirus (HCoV) 229E/NL63, parain-
fluenza virus (PIFV) 1, PIFV 2, and PIFV 3, and the Seep-
lexTM RV detection kit B is designed to detect IFV A, IFV
B, RSV A, RSV B, rhinovirus (RhV), and HCoV OC43/
HKU1. Each PCR was conducted in a final reaction volume
of 20 µL containing 3 µL of cDNA, 3 µL of 8-methoxy-
psoralen (MOP) solution, 4 µL of 5×RV Primer, and 10
µL of 2×master mix. The PCR protocol was 94˚C for 30
sec, followed by 35 cycles of 60˚C for 1.5 min, and 72˚C
for 1.5 min, followed by a 10 min final extension at 72˚C.
The amplified products were separated on a 2% agarose
gel stained with ethidium bromide. Each run included a
molecular size marker and internal control. Also, Ameri-
can Type Culture Collection (ATCC) standard viruses
were used for positive control and 10 µL distilled water as
negative control. 
LabopassTM RV detection kit 
(http://www.cosmo4.com/index_eng.html ) 
Nucleic acids from nasopharyngeal aspirates were also
used for the LabopassTM kit. This kit was also designed to
detect 12 types of viruses. The final reaction volume was
50 µL composed of 40 µL premixture and 10 µL nucleic
acid. Two kinds of PCR protocols were used. AdV and
human bocavirus (HboV) operated at 95˚C for 3 min, then
35 cycles of 95˚C for 1 min, 55˚C for 1 min, and 72˚C for 1
min, followed by a 5 min final extension at 72˚C and
preserved at 4˚C. HCoV, EnV, PIFV, RhV, and RSV all
operated at 42˚C for 60 min, 95˚C for 3 min, then 35 cycles
of 95˚C for 1 min, 55˚C for 1 min, and 72˚C for 1 min,
followed by a 5 min final extension at 72˚C and preserved
at 4˚C. The PCR products were analyzed by identifying
bands with a 2% agarose gel stained with ethidium bromide. 
Virus culture by R-Mix ReadyCells with antigen staining
Samples showing any positive results for AdV, IFV, PIFV,
and RSV from the two multiplex PCR kits were performed
with shell vial cultures by R-Mix ReadyCells (Diagnostic
HYBRIDS, Inc., Athens, OH, USA) according to manu-
facturer’s procedures. Firstly, the cryopreserved R-Mix
cell reagents were heated in a 37˚C heat block for 4 min,
and rinsed with a rinse buffer and then remained for 4 min
at room temperature. In the meantime, the re-feed medium
and 1.0 mL R-Mix ReadyCells were mixed. Then, 200 µL
specimens were inoculated into R-Mix ReadyCells and
centrifuged at 700×g for 60 min at room temperature.
After overnight incubation at 35˚C in the incubator, cell
monolayers of the shell vial were washed and fixed with
acetone, and stained with respiratory virus fluorescent
antibodies by D3 DFA (Diagnostic Hybrids, Inc., Athens,
OH, USA). If virus-specific fluorescence was noted by
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screening, virus identification was performed using indi-
vidual monoclonal antibodies staining (IFV A and B, AdV,
PIFV 1,2,3 and RSV). When the initial screening was
negative, the vial was re-examined on day 3 and day 5. 
Sequencing analysis 
Ten samples, which were culture negative but multiplex
PCR positive, were proceeded with sequencing analysis to
identify these equivocal results. All sequencing analyses
were proceeded after repeating PCR then proper primers
were prepared for specific viruses identification. An auto-
mated sequencing analyzer (Applied Biosystems, Foster
City, CA, USA) accompanied with its recommended reagent
was used according to the manufacturer’s protocol. Finally,
results of all sequences were analyzed by matching those
of GenBank data using Basic Local Alignment Search
Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Nucleic acid amplification results by 2 kinds of 
multiplex PCR  
The basic characteristics and major results of 220 pediatric
patients are summarized in Table 1. The positive rate of
the SeeplexTM RV detection kit was 52.7% (116 positive
samples/total 220 samples). SeeplexTM identified 136
viruses which were the sum of AdV (n = 14, 10.3%),
HCoV 229E/NL63 (n = 5, 3.7%), HCoV OC43/HKU1 (n =
4, 2.9%), IFV A (n = 8, 5.9%), IFV B (n = 9, 6.6%), HMPV
(n = 2, 1.5%), PIFV 1 (n = 0, 0%), PIFV 2 (n = 0, 0%),
PIFV 3 (n = 4, 2.9%), RhV A/B (n = 18, 13.2%), RSV A (n
= 39, 28.7%), and RSV B (n = 33, 24.3%). 
The LabopassTM RV detection kit showed 46.4% posi-
tivity (102 positive samples/total 220 samples). The Labo-
passTM RV detection kit identified 116 viruses which were
the sum of AdV (n = 14, 12.1%), HBoV (n = 4, 3.4%),
HCoV NL63 (n = 1, 0.9%), HCoV OC43 (n = 2, 1.7%), EV
(n = 0, 0%), IFV A (n = 2, 1.7%), IFV B (n = 2, 1.7%),
HMPV (n = 22, 19.0%), PIFV 1 (n = 2, 1.7%), PIFV 2 (n =
0, 0%), PIFV 3 (n = 1, 0.9%), RhV A/B (n = 6, 5.2%), and
RSV (n = 60, 51.7%). The coinfection (more than 2 virus
species identified) rate of the SeeplexTM RV kit was 6.8%
(15/220) and of the LabopassTM RV kit was 5.9% (13/220).  
Shell vial cultures with direct immunostaining for 
identifying AdV, IFV, PIFV, and RSV
If one or more of the viruses were identified from a multi-
plex PCR, R-Mix ReadyCell cultures were proceeded with
direct immunofluorescence staining. There were 103
samples that showed a positive multiplex PCR of AdV,
IFV, PIFV, and RSV. The shell vial culture assay showed
93 positive samples of the total 103 samples (positive rate
90.3%). There were two samples which showed 2 kinds of
viruses. A total of 95 positive numbers of the R-Mix culture
was noted from 15 AdV, 6 IFV A, 9 IFV B, 2 PIFV, and 63
RSV. Positive viral culture rate from the SeeplexTM RV de-
tection kit was 96.1% (99 samples of the total 103 samples)
and that of the LabopassTM RV detection kit was 77.7% (80
samples of the total 103 samples).
Fifty samples of the 103 total samples showed the same
results by the two kinds of multiplex PCR and viral culture.
However, there were 53 samples which showed discrepant
results by each test. The 53 results were divided into 5
groups according to discrepant characters (Table 2). The
R-Mix culture which we used in this study targeted only
four viruses (AdV, IFV, PIFV, and RSV), and so other
viruses could not be isolated. The positive results of multi-
plex PCR and R-Mix culture for detecting AdV, IFV,
PIFV, and RSV are compared in Fig. 1. 
Sequencing results of multiplex PCR positive but viral 
culture negative samples
Ten samples of culture negative but any multiplex PCR
positive were further analyzed by sequencing. The results
are showed in Table 3. The corresponding viruses were
identified with a homology of 91-100%. Of the ten sequenc-
ing results, nine were consistent with multiplex PCR results.
There was one completely discrepant result between
multiplex PCR and sequencing analysis (Case No. 10: IFV
A versus RhV, Table 3). 
Rapid and accurate identification of causative agents in viral
RESULTS
Table 1. Basic Characteristics of 220 Pediatric Patients
Patients’ characteristcs Value
Age [mean ± SD; (range)] 2.5 yrs ± 1.4; (0 - 6)
Sex ratio (M : F) 1.3 (124 : 96)
Final diagnosis Viral pneumonia
No. of positive mutiplex PCR patients (%, Seeplex vs. Labopass) 116 vs. 102 (52.7, 46.4)
No. of positive shell vial culture patients (%, Seeplex vs. Labopass)* 99 vs. 80 (96.1, 77.7)
*Total 103 samples were proceeded shell vial cultures.
DISCUSSION
pneumonia of pediatric patients is essential to prevent
disease propagation. It is also helpful for early initiation of
proper management. An early start of proper anti-viral
management can reduce unnecessary overuse of antibac-
terial agents. In addition, some respiratory viruses, including
IFV, EnV, and AdV, may now benefit from specific antivi-
ral treatment.6-8 So, we designed and performed this study to
evaluate two kinds of multiplex PCR kits and a commercial
shell vial culture method for their clinical efficacy with
prospectively collected samples of pediatric patients. 
Until now, virus isolation by a cell culture and a direct
immunofluorescent antigen staining assay has been the
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Table 2. Comparison Results of Multiplex PCR Positive Cases
Multiplex PCR Multiplex PCR 
R-Mix culture
Total no.
(SeeplexTM) (LabopassTM) (103 cases)
Consistent (50) AdV AdV AdV 10
IFV B IFV B IFV B 2
RSV A RSV RSV 38
Inconsistent (36) AdV AdV + IFV A + RhV AdV + IFV A 1
AdV hMPV + PIFV 3 PIFV 3 1
AdV Negative AdV 1
IFV A Negative IFV A 4
IFV A Negative IFV B 1
IFV A Negative No growth 1
IFV A Negative No growth 1
IFV A Negative No growth 1
IFV B Negative IFV B 5
IFV B + RSV A Negative RSV + IFV B 1
IFV B + RSV A RSV RSV 1
hMPV + RSV B hMPV No growth 1
Negative IFV A IFV A 1
Negative MPV + PIFV 1 No growth 1
Negative RSV RSV A + RSV B 2
PIFV 3 AdV AdV 1
PIFV 3 + RhV A/B Negative No growth 1
PIFV 3 + RhV A/B PIFV 1 PIFV 3 1
PIFV 3 + RhV A/B + RSV B AdV AdV 1
RSV A Negative No growth 2
RSV A Negative RSV 4
RSV A RSV No growth 1
RSV A + RSV B Negative RSV 1
RSV B RSV No growth 1
Indeterminate (17) AdV + HCoV OC43 AdV + HCoV OC43 AdV 1
HCoV 229E/NL63 + RSV B RSV RSV 3
HCoV OC43 + RSV A RSV RSV 1
HCoV OC43 + RSV B RSV RSV 1
HCoV 229E/NL63 + RSV A RSV RSV 1
RhV A/B + RSV A RSV RSV 2
RSV A hMPV + RSV RSV 3
RSV A + RSV B RSV + HBoV RSV 1 
RSV B hMPV + RSV RSV 2
RSV B RSV + hMPV RSV 2
PCR, polymerase chain reaction; AdV, adenovirus; HCoV, human coronavirus; IFV, influenza virus; PIFV, parainfluenza virus; hMPV, human 
metapneumovirus; RhV, rhinovirus; RSV, respiratory syncytial virus; HBoV, human bocavirus.
*R-Mix culture could only detect AdV, IFV, PIFV and RSV in this study.
most commonly used method for identifying respiratory
viruses.9 An enzyme immunoassay may be quicker but it is
less sensitive. These conventional methods may be affect-
ed by specimen quality, virus type, and technical skill.10-12
The virus culture is still considered the gold standard for
respiratory virus detection, but it has limitations in turnaro-
und time, specimen transport, and storage conditions in
maintaining the infectivity of the virus.11,13 To compare the
test methods, Choi, et al.14 reported that the positive rate of
the direct antigen test, viral culture method, and multiplex
PCR for detecting AdV, IFV, PIFV, and RSV was 28.4%,
36.2%, and 44.8%, respectively. 
Recently, virus identification by immunostaing after
shell vial culture is the most widely accepted laboratory
standard method of virus testing. But, this method is still
not easy for routine testing in clinical laboratories. The
nucleic acid amplification method including multiplex
PCR is a powerful alternative, but it has some limitations
of false positivity and false negativity. The nucleic acid
amplification test is faster than the culture method and has
been reported to be more sensitive9,15-17 and can be auto-
mated these days. In addition, there are advantages in
detecting some viruses which grow poorly in cell cultures
such as HMPV.18 
A Korean national survey19 of respiratory virus testing
was performed and thirty-one clinical laboratories respond-
ed that they provided respiratory virus testing for clinical
diagnosis in Korea. Among the responders, PCR and/or
culture were most widely adopted, in 42% of the institutes,
rapid immunochromatographic method 29%, immunofluo-
rescent antigen assay 23%, and enzyme immunoassay 7%. 
We focused on the four major respiratory viruses of
AdV, IFV, PIFV, and RSV. The exact concordance rate
between the two kinds of multiplex PCR and R-Mix viral
culture was 48.5% (50/103). Our results of the two multi-
plex PCR showed an equivalent or higher positive rate than
in other studies.9,10,14 Two kinds of multiplex PCR reagents
showed different positivity according to the virus type. The
positive rate of the SeeplexTM RV detection kit was higher
than the LabopassTM RV kit for IFV and RhV. However, the
Identification of Pediatric Respiratory Virus
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Fig. 1. Comparison of multiplex PCRs and R-Mix culture for detecting adenovirus (AdV), influenza virus (IFV), parainfluenza virus (PIFV) and
respiratory syncytial virus (RSV) in pediatric patients with viral pneumonia.
Table 3. Sequencing Confirmations of 10 Samples that Showed Multiplex PCR Positive and Culture Negative Results
% Homology
Case Gender Age Respiratory Multiplex PCR Multiplex PCR R-Mix Sequencing based on 
no. (M : 1, F : 2) (mo) disease (SeeplexTM) (LabopassTM) culture results maximum 
identity (%)*
1 1 56 Viral Pneumonia IFV A Negative No growth RSV A + RSV B + IFV A 100 + 98 + 97
2 2 22 Viral Pneumonia IFV A Negative No growth IFV A 99
3 1 28 Viral Pneumonia RSV A Negative No growth RSV A 98
4 2 16 Viral Pneumonia RSV A Negative No growth RSV A 97
5 1 51 Viral Pneumonia RSV A RSV No growth RSV A 97
6 2 19 Viral Pneumonia RSV B RSV No growth RSV B 98
7 2 38 Viral Pneumonia hMPV + RSV B hMPV No growth hMPV 98
8 2 20 Viral Pneumonia PIFV 3 + RhV A/B Negative No growth RhV A 91
9 2 50 Viral Pneumonia Negative hMPV + PIFV No growth hMPV 98
10 1 46 Viral Pneumonia IFV A Negative No growth RhV A 97
PCR, polymerase chain reaction; IFV, influenza virus; PIFV, parainfluenza virus; hMPV, human metapneumovirus; RhV, rhinovirus; RSV, respiratory syncytial virus.
*Respiratory viruses were confirmed by the Basic Local Alignment Search Tool (BLAST) program. 
LabopassTM RV kit detected more HMPV than the Seepl-
exTM RV kit.    
Discrepant results between these two types of multiplex
PCR and R-Mix culture comprised 51.5% (53/103) of the
total. Weinberg, et al.17 reported that the PCR method could
detect viruses two times more, compared with virus culture.
Our study showed that the concordance rate of Seeplex
PCR to the virus culture was 83% (90/103), and that of
Labopass PCR, 80.6% (83/103). These results were similar
to previous reports, of 83.2% (556/668)17 and 80% (40/50).20
The discrepancy might be caused from multiplex PCR
limitations. One of the major limitations of PCR detection
is false-negative results as a consequence of PCR inhibitors
present in clinical samples that are not removed by the
extraction process.9 Another limitation is the principle of
PCRs, which could produce false results if a primer region
has nucleotide variation and is unable to detect new types
or strains of a virus. This is the reason that direct antigen
tests or virus cultures cannot be completely substituted by
solitary multiplex PCR tests until now.21
We noticed a 6.8% (15/220) coinfection rate (more than
2 virus types identified) by the SeeplexTM RV kit and 5.9%
(13/220) by the LabopassTM RV kit. Previous studies have
suggested that double-virus infections are associated with
greater severity of respiratory tract infection.22 In our study,
we could not find out any remarkable parameters or differ-
ence of clinical severity in cases of coinfection. 
Ten cases of culture negative but multiplex PCR posi-
tive were further evaluated by direct sequencing in our
study. Sequencing results confirmed almost all the original
results of multiplex PCR.  
In conclusion, identification of respiratory viruses by
multiplex PCR can be more rapid, an easier method, and
show more positive results than the viral culture method.
Hence, multiplex PCR can be the first choice for detection
of respiratory viruses in a clinical laboratory. Other comple-
mentary efforts such as viral cultures and sequencing
methods could be selectively proceeded in selected cases
according to each laboratory’s environment. 
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